We report on a novel, successful, non-cytotoxic therapy to treat multiply-refractory T-LGL in an elderly patient.
Zawit, M., Gurnari, C., Pagliuca, S., Awada, H., Maciejewski, J.p., Saunthararajah, Y. (2021). A non-cytotoxic regimen of decitabine to treat refractory T-cell large granular lymphocytic leukemia. CLINICAL CASE REPORTS, 9(9) [10.1002/ccr3.4533].
A non-cytotoxic regimen of decitabine to treat refractory T-cell large granular lymphocytic leukemia
Gurnari, CarmeloConceptualization
;
2021-09-01
Abstract
We report on a novel, successful, non-cytotoxic therapy to treat multiply-refractory T-LGL in an elderly patient.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Clinical Case Reports - 2021 - Zawit - A non‐cytotoxic regimen of decitabine to treat refractory T‐cell large granular.pdf
accesso aperto
Licenza:
Creative commons
Dimensione
369.72 kB
Formato
Adobe PDF
|
369.72 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
